Center for Financial Planning’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58K Hold
30
﹤0.01% 575
2026
Q1
$2.71K Hold
30
﹤0.01% 562
2025
Q4
$2.7K Hold
30
﹤0.01% 596
2025
Q3
$2.96K Hold
30
﹤0.01% 573
2025
Q2
$2.74K Hold
30
﹤0.01% 546
2025
Q1
$3.4K Hold
30
﹤0.01% 556
2024
Q4
$3.17K Hold
30
﹤0.01% 511
2024
Q3
$3.24K Sell
30
-80
-73% -$8.73K ﹤0.01% 478
2024
Q2
$11.9K Sell
110
-15
-12% -$1.77K ﹤0.01% 374
2024
Q1
$16.5K Buy
125
+15
+14% +$1.87K ﹤0.01% 344
2023
Q4
$13.4K Hold
110
﹤0.01% 337
2023
Q3
$12.3K Hold
110
﹤0.01% 337
2023
Q2
$16K Hold
110
﹤0.01% 332
2023
Q1
$14.2K Hold
110
﹤0.01% 323
2022
Q4
$14K Sell
110
-4,000
-97% -$464K ﹤0.01% 318
2022
Q3
$430K Sell
4,110
-8
-0.2% -$878 0.11% 78
2022
Q2
$433K Hold
4,118
0.11% 79
2022
Q1
$527K Sell
4,118
-124
-3% -$14.9K 0.11% 79
2021
Q4
$523K Buy
4,242
+9
+0.2% +$1.18K 0.11% 79
2021
Q3
$602K Hold
4,233
0.15% 69
2021
Q2
$661K Hold
4,233
0.16% 68
2021
Q1
$658K Hold
4,233
0.17% 66
2020
Q4
$633K Hold
4,233
0.18% 62
2020
Q3
$560K Hold
4,233
0.18% 61
2020
Q2
$491K Hold
4,233
0.17% 66
2020
Q1
$415K Hold
4,233
0.14% 66
2019
Q4
$615K Buy
+4,233
New +$584K 0.15% 61

Other funds holding ZBH

Center for Financial Planning's ZBH Position: Q2 2026 in Review

Center for Financial Planning held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 30 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #575.

Center for Financial Planning first reported a position in ZBH in Q4 2019 and has held it in 27 quarters since. The position peaked at $661K in Q2 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Center for Financial Planning held 30 shares of Zimmer Biomet worth $2.58K as of Q2 2026.
  • Center for Financial Planning left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Center for Financial Planning's portfolio in Q2 2026, its #575 holding.
  • Center for Financial Planning first reported a position in Zimmer Biomet in Q4 2019 and has held it in 27 quarters since.
  • Center for Financial Planning's Zimmer Biomet position peaked at $661K in Q2 2021.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.